Skip to content

Clinical application of minimally extracorporeal circulation in cardiac surgery for elderly patients

Clinical application of minimally extracorporeal circulation in cardiac surgery for elderly patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077205
Enrollment
Unknown
Registered
2023-11-01
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart-valve disease

Interventions

Experimental group:Applied the mini-cardiopulmonary bypass technology
Control group:Applied the conventional cardiopulmonary bypass technology

Sponsors

Shanghai Geriatric Medicine Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? Consciously sign the informed consent form and follow the requirements of the protocol; ? Age is 70 years old, gender is unlimited; ? Based on the results and history of transthoracic and (or) transesophageal echocardiography, coronary angiography or surgical exploration, the diagnosis of valvular disease or valve disease with coronary heart disease is clear.

Exclusion criteria

Exclusion criteria: ? Unable to tolerate the operation; ? Acute myocardial infarction occurred within 14 days prior to enrollment; ? Mechanical circulatory supportive therapy is being used; ? Haematological diseases; ? History of stroke within 90 days before enrollment, or a history of cerebrovascular disease combined with uncorrected carotid artery stenosis (> 80%); ? Having abdominal aortic aneurysm or thoracic aortic aneurysm (> 5 cm in diameter) or having severe atherosclerosis; ? Uncontrolled infection; ? Severe chronic obstructive pulmonary disease or pulmonary embolism; ? Moderate and above hepatic and renal insufficiency; ? Pulmonary artery systolic pressure over 60 mmHg or pulmonary vascular resistance> 5 Woods Units, transpulmonary pressure 16 mmHg; ? Combined with mental illness, psychological problems or cognitive dysfunction, can not cooperate with the treatment; ? Having a malignant tumor; ? Participate in other investigational drug or device trials in the last three months.

Design outcomes

Primary

MeasureTime frame
Rate of change in hemoglobin level before and after surgery;

Secondary

MeasureTime frame
All-cause mortality at 7 days after surgery;Perioperative rate of cardiopulmonary bypass-related complications;

Countries

China

Contacts

Public ContactYun Zhao

Shanghai Geriatric Medicine Center

dr.zhaoyun@126.com+86 139 1752 6967

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026